Wednesday, October 31, 2018

FDC receives EIR from US health regulator for Waluj plant

FDC receives EIR from US health regulator for Waluj plant The company said it had submitted a detailed compliance report to the US Food and Drug Administration (USFDA) within the stipulated period in response to the Form 483 containing eight observations issued to it by the regulator.

from Moneycontrol Business News https://ift.tt/2DeGRX9

No comments:

Post a Comment

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...